Mark serves as Executive Vice President, International and also has responsibility for our Global Corporate Accounts. He served as President, Europe from October 2012 to December 2016, President EMEA from January 2017 to February 2019. Prior to joining us Mark worked in a number of Senior International Leadership roles with CR Bard, Edwards Life Sciences and Boston Scientific, mainly focusing on the commercialisation of Cardiovascular and Critical Care medical device technology.